fda glp-1 compounding warning october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA unleashes warning letters to

GLP-1 medications can help: Weight loss from these medications reduces sleep apnea severity Studies show they can reduce the Apnea-Hypopnea Index (AHI) by 12-15 events per hour Tirzepatide reduced AHI by 48-56% compared to placebo Since OSA is both a cause and consequence of other health problems, improving sleep breathing can create a cascade of health benefits

Planning meals helps you consume healthier nutrients

Women experiencing similar symptoms can explore hormone replacement therapy, and many TRT patients also complement treatment with IV vitamin therapy for added energy and recovery support

Acknowledgements We thank F

10.1016/j.jpsychires.2019.09.009 70